REDWOOD CITY, Calif. and HELSINKI – July 16, 2020 – MariaDB® Corporation today announced the general availability of MariaDB Platform X5, a comprehensive open source database solution delivering the ultimate in versatility across workloads and scalability from a single database or data warehouse to millions of transactions per second. This major release introduces powerful upgrades … Continued

MariaDB Community Server 10.5 turns into analytics powerhouse with cloud-native storage REDWOOD CITY, Calif. and HELSINKI – June 24, 2020 – MariaDB® Corporation today announced the general availability of MariaDB Community Server 10.5, a major new release that brings high-performance analytics to the hands of millions using the popular open source database. In a push … Continued

Original Article from The Verge In October, Razer announced Junglecat, a mobile gamepad with two Nintendo Switch Joy-Con-like controllers that attached to either side of your phone, but it only worked with four Android phones and required that you put your phones in a special case when you used it. Today at CES, just a few … Continued

REDWOOD CITY, Calif. and HELSINKI – May 13, 2020 – MariaDB® Corporation today announced the immediate availability of MariaDB SkySQL Power, the first database-as-a-service (DBaaS) offering that lets enterprises customize options and configurations to fit their distinct requirements. Built on top of SkySQL’s Foundation, which delivers the complete MariaDB Platform experience in the cloud, Power … Continued

IRVINE, Calif.–(BUSINESS WIRE)– AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today that updates from ongoing clinical trials in ovarian cancer and glioblastoma were presented as part of the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting I. The presentation from Daniela Bota, MD, Ph.D., of the University … Continued

Leader of Series B-2 Financing Round Matthew Katz Joins AIVITA’s Board of Directors IRVINE, Calif., Feb. 25, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a biotechnology company (the “Company”) specializing in innovative stem cell applications, announced today the first closing of its $25 million Series B-2 preferred stock investment round. The first closing of $12.5 million was … Continued

IRVINE, Calif., Aug. 14, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today updated clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting tumor-initiating cells. Blood plasma biomarker analyses have identified a robust immune response and a decrease of tumor biomarkers in … Continued